285 related articles for article (PubMed ID: 34667307)
41. Immune transcriptomes of highly exposed SARS-CoV-2 asymptomatic seropositive versus seronegative individuals from the Ischgl community.
Lee HK; Knabl L; Pipperger L; Volland A; Furth PA; Kang K; Smith HE; Knabl L; Bellmann R; Bernhard C; Kaiser N; Gänzer H; Ströhle M; Walser A; von Laer D; Hennighausen L
Sci Rep; 2021 Feb; 11(1):4243. PubMed ID: 33608566
[TBL] [Abstract][Full Text] [Related]
42. The role of asymptomatic infections in influenza transmission: what do we really know.
Montgomery MP; Morris SE; Rolfes MA; Kittikraisak W; Samuels AM; Biggerstaff M; Davis WW; Reed C; Olsen SJ
Lancet Infect Dis; 2024 Jun; 24(6):e394-e404. PubMed ID: 38128563
[TBL] [Abstract][Full Text] [Related]
43. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
[TBL] [Abstract][Full Text] [Related]
44. Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection.
Choe PG; Kim KH; Kang CK; Suh HJ; Kang E; Lee SY; Kim NJ; Yi J; Park WB; Oh MD
Emerg Infect Dis; 2021 Mar; 27(3):928-931. PubMed ID: 33350923
[TBL] [Abstract][Full Text] [Related]
45. Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.
Mattar S; Martinez-Bravo C; Rivero R; Contreras H; Faccini-Martínez ÁA; Guzman-Teran C; Galeano K; Alvis-Guzman N; Contreras V; Arrieta G; Gonzalez-Tous M; Miranda J; Ospina M; Camargo-Assis F; Mercado-Reyes M; Garay E; Garcia-Perez A; Lopez Y; Tique V
Ann Clin Microbiol Antimicrob; 2020 Dec; 19(1):58. PubMed ID: 33287846
[TBL] [Abstract][Full Text] [Related]
46. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
47. Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands.
McDonald SA; Miura F; Vos ERA; van Boven M; de Melker HE; van der Klis FRM; van Binnendijk RS; den Hartog G; Wallinga J
Eur J Epidemiol; 2021 Jul; 36(7):735-739. PubMed ID: 34114187
[TBL] [Abstract][Full Text] [Related]
48. A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.
Meyers KJ; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
J Med Virol; 2020 Nov; 92(11):2874-2879. PubMed ID: 32543722
[TBL] [Abstract][Full Text] [Related]
49. Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
Mazzoni A; Maggi L; Capone M; Spinicci M; Salvati L; Colao MG; Vanni A; Kiros ST; Mencarini J; Zammarchi L; Mantengoli E; Menicacci L; Caldini E; Romagnani S; Liotta F; Morettini A; Rossolini GM; Bartoloni A; Cosmi L; Annunziato F
Eur J Immunol; 2020 Dec; 50(12):2013-2024. PubMed ID: 33080068
[TBL] [Abstract][Full Text] [Related]
50. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.
Ansari A; Arya R; Sachan S; Jha SN; Kalia A; Lall A; Sette A; Grifoni A; Weiskopf D; Coshic P; Sharma A; Gupta N
Front Immunol; 2021; 12():636768. PubMed ID: 33777028
[TBL] [Abstract][Full Text] [Related]
51. Children and Adults With Mild COVID-19: Dynamics of the Memory T Cell Response up to 10 Months.
Kaaijk P; Pimentel VO; Emmelot ME; Poelen MCM; Cevirgel A; Schepp RM; den Hartog G; Reukers DFM; Beckers L; van Beek J; van Els CACM; Meijer A; Rots NY; de Wit J
Front Immunol; 2022; 13():817876. PubMed ID: 35197982
[TBL] [Abstract][Full Text] [Related]
52. SARS-CoV-2-specific antibody rearrangements in prepandemic immune repertoires of risk cohorts and patients with COVID-19.
Paschold L; Simnica D; Willscher E; Vehreschild MJ; Dutzmann J; Sedding DG; Schultheiß C; Binder M
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33064671
[TBL] [Abstract][Full Text] [Related]
53. Asymptomatic COVID-19 in hospital visitors: The underestimated potential of viral shedding.
Passarelli VC; Faico-Filho K; Moreira LVL; Cunha AP; Carvalho JMA; Barbosa GR; Camargo C; Conte DD; Perosa AH; Bellei N
Int J Infect Dis; 2021 Jan; 102():412-414. PubMed ID: 33129961
[TBL] [Abstract][Full Text] [Related]
54. Transmission frequency of COVID-19 through pre-symptomatic and asymptomatic patients in AJK: a report of 201 cases.
Mahmood M; Ilyas NU; Khan MF; Hasrat MN; Richwagen N
Virol J; 2021 Jul; 18(1):138. PubMed ID: 34217301
[TBL] [Abstract][Full Text] [Related]
55. Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
Li W; Su YY; Zhi SS; Huang J; Zhuang CL; Bai WZ; Wan Y; Meng XR; Zhang L; Zhou YB; Luo YY; Ge SX; Chen YK; Ma Y
Clin Microbiol Infect; 2020 Nov; 26(11):1556.e1-1556.e6. PubMed ID: 32653662
[TBL] [Abstract][Full Text] [Related]
56. SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults.
Björkander S; Du L; Zuo F; Ekström S; Wang Y; Wan H; Sherina N; Schoutens L; Andréll J; Andersson N; Georgelis A; Bergström A; Marcotte H; Kull I; Hammarström L; Melén E; Pan-Hammarström Q;
J Allergy Clin Immunol; 2022 Jan; 149(1):65-75.e8. PubMed ID: 34695490
[TBL] [Abstract][Full Text] [Related]
57. Descriptive, Retrospective Study of the Clinical Characteristics of Asymptomatic COVID-19 Patients.
Han H; Xu Z; Cheng X; Zhong Y; Yuan L; Wang F; Li Y; Liu F; Jiang Y; Zhu C; Xia Y
mSphere; 2020 Oct; 5(5):. PubMed ID: 33028689
[TBL] [Abstract][Full Text] [Related]
58. Infection and disease spectrum in individuals with household exposure to SARS-CoV-2: A family cluster cohort study.
Xie W; Chen Z; Wang Q; Song M; Cao Y; Wang L; Pan CQ
J Med Virol; 2021 May; 93(5):3033-3046. PubMed ID: 33538342
[TBL] [Abstract][Full Text] [Related]
59. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
Le Bert N; Clapham HE; Tan AT; Chia WN; Tham CYL; Lim JM; Kunasegaran K; Tan LWL; Dutertre CA; Shankar N; Lim JME; Sun LJ; Zahari M; Tun ZM; Kumar V; Lim BL; Lim SH; Chia A; Tan YJ; Tambyah PA; Kalimuddin S; Lye D; Low JGH; Wang LF; Wan WY; Hsu LY; Bertoletti A; Tam CC
J Exp Med; 2021 May; 218(5):. PubMed ID: 33646265
[TBL] [Abstract][Full Text] [Related]
60. Pregnant Women Develop a Specific Immunological Long-Lived Memory Against SARS-COV-2.
Fenizia C; Cetin I; Mileto D; Vanetti C; Saulle I; Di Giminiani M; Saresella M; Parisi F; Trabattoni D; Clerici M; Biasin M; Savasi V
Front Immunol; 2022; 13():827889. PubMed ID: 35251011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
